Marksans Pharma's arm gets UK MHRA grant for market authorisation of Loperamide Capsules

09 Dec 2021 Evaluate

UK MHRA has granted market authorisation to Marksans Pharma's wholly owned subsidiary Relonchem for Loperamide 2mg Hard Capsules. Marksans will manufacture the products at its UK MHRA approved state-of-the-art oral dosage facility located at Goa, India.

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×